[Latest] Global Metaverse In E-commerce Market Size/Share Worth USD 110.6 Billion by 2033 at a 39.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
23. September 2024 15:00 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Metaverse In E-commerce Market Size, Trends and Insights By Platform (Desktop,...
National Comedy Theatre to celebrate 25 years of bringing laughter to the community
18. Juli 2024 10:00 ET
|
National Comedy Theatre
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- San Diego’s funniest night out is celebrating 25 years of laughs with the community this fall. National Comedy Theatre has entertained audiences of all...
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
24. April 2023 07:00 ET
|
Unity Biotechnology, Inc.
A single injection of UBX1325 led to a statistically significant and clinically meaningful improvement in Best Corrected Visual Acuity (BCVA) of +6.2 ETDRS letters from baseline at 48 weeks ...
UNITY Biotechnology to Host Program Update on BEHOLD, the Phase 2 Clinical Trial of UBX1325 in Patients with Diabetic Macular Edema
23. April 2023 18:00 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., April 23, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases...
UNITY Biotechnology Completes Enrollment in Phase 2 ENVISION Study of UBX1325 in Wet Age-related Macular Degeneration
19. September 2022 08:00 ET
|
Unity Biotechnology, Inc.
Enrollment of 51 patients exceeds target by ~10% due to high interest in the study 16-week data anticipated in Q1 2023 and 24-week data anticipated in Q2 2023 SOUTH SAN FRANCISCO, Calif., Sept. 19,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Unity, Amazon, Outset Medical, and Missfresh and Encourages Investors to Contact the Firm
31. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm
26. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inotiv, Wells Fargo, Unity, and Amazon and Encourages Investors to Contact the Firm
21. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yext, Inotiv, Wells Fargo, and Unity Software and Encourages Investors to Contact the Firm
15. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm
10. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...